Indo US Bio-Tech Ltd.

BSE: 541304 SECTOR: Trading  4431   53   1

90.00
-3.65 (-3.90%)
BSE: 02 Dec 4:00 PM

Price Summary

Today's High

₹ 90.25

Today's Low

₹ 90

52 Week High

₹ 104.8

52 Week Low

₹ 0

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

65.53 Cr.

Enterprise Value

73.91 Cr.

No. of Shares

0.73 Cr.

P/E

12.85

P/B

2.88

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  31.23

CASH

0.2 Cr.

DEBT

8.58 Cr.

Promoter Holding

73.01 %

EPS (TTM)

₹  7

Sales Growth

21.16%

ROE

16.74 %

ROCE

16.65%

Profit Growth

21.38 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year0.82%
3 Year10.61%
5 Year16.04%

Profit Growth

1 Year101.13%
3 Year52.09%
5 Year69.92%

ROE%

1 Year26.87%
3 Year21.94%
5 Year22.39%

ROCE %

1 Year18.3%
3 Year18.43%
5 Year19.48%

Debt/Equity

0.533

Price to Cash Flow

-83.43

Interest Cover Ratio

4.24004168928023

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2021 73.01 0
Jun 2021 73.01 0
Mar 2021 73.01 0
Dec 2020 73.01 0
Sep 2020 72.19 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 21.9421952881745% over the past 3 years.
  • The company has a high promoter holding of 73.01%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Net Sales 24.51 29.62 35.49 39.76 40.09
Total Expenditure 23.27 26.92 32.07 35.8 34.57
Operating Profit 1.24 2.7 3.42 3.96 5.51
Other Income 0.07 0.22 0.03 0.01 0.04
Interest 0.64 0.72 0.4 0.88 1.18
Depreciation 0.15 0.15 0.24 0.21 0.25
Exceptional Items 0 0 0 -0.01 0
Profit Before Tax 0.52 2.04 2.81 2.86 4.13
Tax 0.13 0.59 0.72 0.33 -0.97
Net Profit 0.4 1.45 2.09 2.53 5.1
Adjusted EPS (Rs.) 1.77 2.82 2.87 3.48 7

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 1.49 3.42 4.85 6.07 6.07
Total Reserves 2 1.52 9.05 10.37 15.47
Borrowings 0.46 1.37 0.66 0.8 3.31
Other N/C liabilities -0.44 0.12 0.62 0.73 0.56
Current liabilities 8.59 10.42 8.68 16.73 18.01
Total Liabilities 12.11 16.85 23.86 34.7 43.42
Assets
Net Block 1.21 1.5 1.37 1.41 2.33
Capital WIP 0 0 1.17 1.28 1.99
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0.01
Loans & Advances 0.02 0.02 0.06 0.08 0.94
Other N/C Assets 0 0.06 0.04 0.03 0.01
Current Assets 10.88 15.27 21.22 31.9 38.13
Total Assets 12.11 16.85 23.86 34.7 43.42
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Profit from operations 0.59 2.04 2.81 2.86 4.13
Adjustment 0.26 0.75 0.7 1.1 1.42
Changes in Assets & Liabilities -0.72 -3.22 -6.68 -4.77 -5.19
Tax Paid -0.07 -0.45 0 -0.03 -0.14
Operating Cash Flow 0.07 -0.88 -3.17 -0.84 0.22
Investing Cash Flow -0.17 0.31 -2.56 -0.57 -1.75
Financing Cash Flow 0.05 0.59 5.74 1.53 1.46
Net Cash Flow -0.05 0.02 0.01 0.12 -0.07

Corporate Actions

Investors Details

PARTICULARS Sep 2020% Dec 2020% Mar 2021% Jun 2021% Sep 2021%
Promoters 72.19 73.01 73.01 73.01 73.01
jagdishkumar devji... 65.84 65.84 65.84 65.84 65.84
malti jagdishbhai ... 2.64 2.64 2.64 2.64 2.64
indo us agriseeds ... 1.65 2.47 2.47 2.47 2.47
priyanka jagdishbh... 2.06 2.06 2.06 2.06 2.06
PARTICULARS Sep 2020% Dec 2020% Mar 2021% Jun 2021% Sep 2021%
Investors 27.81 26.99 26.99 26.99 26.99
bhartiben rajendra... 1.24 1.24 1.24 1.24 1.24
pratik rajendrabha... 2.06 2.06 2.06 2.06 2.06
tejas rohitkumar s... 1.13 - - - -
sushil financial s... - - - - -
natvarsinh t chavd... - - - 1.57 1.52
jayeshkumar waghji... - - - - -
sarlaben jayeshkum... 1.19 - - - -
vipul rajendrabhai... 1.03 1.03 1.03 1.03 1.03
madhuben dhirajlal... 1.03 1.03 1.03 1.03 1.03
gandhi rajendra dh... - - - 1.03 1.03
gandhi rajendra dh... 1.03 1.03 1.03 - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Indo US Bio-Tech Stock Price Analysis and Quick Research Report. Is Indo US Bio-Tech an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Indo US Bio-Tech has a PE ratio of 12.854939153288 which is low and comparatively undervalued .

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Indo US Bio-Tech has ROA of 8.6567759109051 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Indo US Bio-Tech has a Current ratio of 1.87229616514445 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Indo US Bio-Tech has a ROE of 16.7431684225905 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Indo US Bio-Tech has a D/E ratio of 0.5227 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Indo US Bio-Tech has an Inventory turnover ratio of 4.33009298159616 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Indo US Bio-Tech has reported revenue growth of 21.1592309930614 % which is fair in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Indo US Bio-Tech for the current financial year is 9.21750480554813 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Indo US Bio-Tech is Rs 0 and the yield is 0 %.

Brief about Indo US Bio-Tech

X